Drug Class
combination of long-acting insulin and GLP-1 receptor agonist
Type
brand
Active Ingredient
insulin degludec and liraglutide
📋Overview
Xultophy is a combination medication that contains insulin degludec and liraglutide. It is used to help manage blood sugar levels in adults with type 2 diabetes. The medication works by combining the effects of a long-acting insulin with a glucagon-like peptide-1 (GLP-1) receptor agonist. Xultophy is generally prescribed when other diabetes treatments have not provided adequate blood sugar control.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Xultophy
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.
